A trifluoromethyl quinazoline derivative and its preparation method and application

By reacting trifluoroacetylcoumarin and quinazolinone compounds at 110-130°C, the efficient synthesis of trifluoromethyl quinazolinone derivatives is achieved without catalysts and solvents, and the existing solutions are solved The problem of using expensive metal catalysts and high temperature and high pressure in the technology has achieved green and environmentally friendly high yield synthesis and good antibacterial and antibacterial effects.

CN116375691BActive Publication Date: 2024-12-06HENAN TOBACCO CO PINGDINGSHAN CO
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202310067910.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-06
Publication Date
2024-12-06
Estimated Expiration
2043-02-06

AI Technical Summary

Technical Problem

The synthesis process of existing quinazolinone derivatives requires the use of expensive metal catalysts and high temperature and high pressure conditions, and lack of green and environmentally friendly synthesis methods, making it difficult to achieve efficient synthesis without solvents and catalysts.

Method used

Trifluoroacetylcoumarin and quinazolinone compounds were reacted at 110-130°C for 1-3 hours, and purified by silica gel column chromatography, achieving efficient synthesis of trifluoromethylquine under catalyst and solvent-free conditions. Zolinone derivatives.

Benefits of technology

It has achieved a high yield, green and environmentally friendly synthesis process, has good antibacterial and antibacterial effects, is suitable for large-scale production, and has expanded the synthesis strategy of quinazolinone derivatives.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116375691B_ABST
    Figure CN116375691B_ABST
Patent Text Reader

Abstract

The present invention relates to a trifluoromethyl-containing quinazolinone derivative, the structural formula of which is as follows: wherein the substituent R 1 is -H, -Br, -OMe or -Me; the substituent R 2 For ‑H, ‑Me, ‑NO 2、 -CF3, -F, -Cl, -Br or -OMe; the substituent R 1 and the substituent R 2 The number of is 1 or more than 2. The trifluoromethyl quinazolinone derivative has good antibacterial and antimicrobial effects, and no catalyst and solvent need to be added during the preparation process. The reaction conditions are green and environmentally friendly, the yield is high, and it has a prospect for large-scale production and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chemical synthesis, and specifically relates to a trifluoromethyl-containing quinazolinone derivative and a preparation method and application thereof. Background Art

[0002] Nitrogen-containing heterocycles are common skeleton compounds in many natural products and have a wide range of applications in the pharmaceutical field. Among them, quinazolinone derivatives have attracted widespread attention from chemists due to their significant biological activities (as shown below).

[0003]

[0004] In recent years, carbon-hydrogen bond functionalization has been recognized as an effective method for constructing carbon-carbon bonds and carbon-heteroatom bonds. Azaaromatics are an important class of organic molecules, such as 2-methylpyridine, 2-methylquinoline, etc., and the activation of carbon-hydrogen bonds of α-methyl SP3 provides new ideas for synthetic chemistry. Shaikh reported the benzylic carbon-hydrogen bond functionalization of alkyl azaaromatics with α-trifluoromethylated carbonyl compounds catalyzed by ytterbium triflate (the synthetic route is shown below). In 2015, Teo described the carbon-hydrogen bond functionalization of α-alkylated aromatics with trifluoromethyl ketones catalyzed by indium trichloride. Although the reaction proceeded smoothly, expensive rare metal catalysts and high reaction temperatures were necessary. Based on this precedent, Teo observed that ferric chloride catalysts could also catalyze the reaction.

[0005]

[0006] A literature survey showed that most reported reactions were limited to the use of metal catalysts. Therefore, considering the potential of green methods in organic synthesis, the development of new strategies to construct quinazolinone derivatives by improving the atom economy of chemical processes and facile and efficient synthesis under solvent-free and catalyst-free methods is a challenging task and is in great demand. Summary of the invention

[0007] The purpose of the present invention is to overcome the defects of the prior art and provide a trifluoromethyl quinazolinone derivative, which has good antibacterial and antimicrobial effects, does not require the addition of catalysts and solvents during the preparation process, has green and environmentally friendly reaction conditions, high yield, and has a prospect for large-scale production and application.

[0008] The present invention also provides a preparation method and application of the trifluoromethyl-containing quinazolinone derivatives.

[0009] To achieve the above object, the present invention adopts the following technical solution:

[0010] A class of trifluoromethyl quinazolinone derivatives, the structural formula of which is shown below:

[0011]

[0012] Among them, the substituent R 1 is -H, -Br, -OMe or -Me; the substituent R 2 is -H, -Me, -NO2, -CF3, -F, -Cl, -Br or -OMe; the substituent R 1 and the substituent R 2 The number of is 1 or more than 2.

[0013] The present invention provides a method for preparing the above-mentioned trifluoromethyl quinazolinone derivatives, which comprises placing a trifluoroacetyl coumarin compound 1 and a quinazolinone compound 2 into a reaction tube, reacting at 110-130° C. for 1-3 hours, and after the reaction, purifying the residue by silica gel column chromatography to obtain the target product derivative 3;

[0014] The reaction synthesis route is as follows:

[0015]

[0016] Specifically, the molar ratio of the trifluoroacetylcoumarin compound 1 to the quinazolinone compound 2 may be 1:1-2.

[0017] More preferably, the reaction may be carried out at 120° C. for 2 hours.

[0018] Further, the residue can be purified by 100-200 mesh silica gel column chromatography.

[0019] Further preferably, the eluent selected for silica gel column chromatography may be dichloromethane and methanol in a volume ratio of 90:1 and 30:1.

[0020] The present invention also provides the use of the trifluoromethyl-containing quinazolinone derivatives in the preparation of antibacterial or antibacterial drugs.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The existing synthesis process requires the use of a catalyst, and the reaction conditions are harsh, which is not conducive to large-scale production and application. The method of the present invention is carried out without using a catalyst and a solvent, and has the advantages of simple operation, few by-products, green and efficient, and a wide range of substrates. In addition, the compound synthesized by the present invention has good antibacterial activity and shows good practical value. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is the single crystal structure diagram of compound 3di;

[0024] Figure 2 For compound 3aa1 H NMR spectrum;

[0025] Figure 3 For compound 3aa 13 C NMR spectrum;

[0026] Figure 4 For compound 3aa 19 F NMR spectrum;

[0027] Figure 5 For compound 3ba 1 H NMR spectrum;

[0028] Figure 6 For compound 3ba 13 C NMR spectrum;

[0029] Figure 7 For compound 3ba 19 F NMR spectrum;

[0030] Figure 8 For compound 3ca 1 H NMR spectrum;

[0031] Fig. 9 For compound 3ca 13 C NMR spectrum;

[0032] Fig.10 For compound 3ca 19 F NMR spectrum;

[0033] Fig.11 For compound 3da 1 H NMR spectrum;

[0034] Fig.12 For compound 3da 13 C NMR spectrum;

[0035] Fig.13 For compound 3da 19 F NMR spectrum;

[0036] Fig.14 For compound 3ea 1 H NMR spectrum;

[0037] Fig.15 For compound 3ea 13 C NMR spectrum;

[0038] Fig.16 For compound 3ea 19 F NMR spectrum. DETAILED DESCRIPTION

[0039] The technical solution of the present invention is further described in detail below in conjunction with the embodiments, but the protection scope of the present invention is not limited thereto.

[0040] In the following examples, unless otherwise specified, the raw materials used are all known compounds disclosed in the prior art, which can be directly purchased from ordinary commercial products or synthesized according to conventional methods in the art.

[0041] Comparative Examples 1 to 9

[0042] This comparative example is mainly used to screen and optimize the best synthesis process parameters and conditions of trifluoromethylquinazolinone derivatives. Specifically, the yield of the product 3aa prepared by raw materials 1a and 2a under different catalysts (such as Na2CO3, DMAP, ZnCl2, InCl3, L-glycine, L-tyrosine and no catalyst), the presence or absence of solvent 1,4-dioxane, different reaction temperatures (90°C, 120°C, 140°C), different reaction times (24h, 2h) and other conditions is given, as shown in Table 1 below. DMAP refers to 4-dimethylaminopyridine, and DCM refers to dichloromethane.

[0043]

[0044] Table 1 Yield of product 3aa under different reaction conditions

[0045]

[0046] The synthesis process of comparative example 1 is as follows: trifluoroacetyl coumarin compound 1a (0.5mmol), quinazolinone compound 2a (0.5mmol), catalyst Na2CO3 (catalyst dosage is 30% of the molar amount of reactant 1a) are loaded into a high temperature reaction tube, and then 3mL of solvent 1,4-dioxane is added, and then reacted at 90°C for 24h. The reaction can be detected by thin layer chromatography (DCM: MeOH = 30: 1, volume ratio) to see if it is complete. After the reaction is completed, the solvent is removed by vacuum distillation, and the residue is purified by 100-200 mesh silica gel column chromatography (the eluent used for column chromatography is dichloromethane and methanol in a volume ratio of 90: 1 and 30: 1), and then the solvent is dried by rotary evaporator to obtain the target product.

[0047] It can be seen from Table 1 that the yields of the product 3aa obtained by comparing different catalysts are significantly different. The experiment found that when no catalyst and solvent were added, the yield of the product obtained was the highest, reaching 90% under the reaction condition of 120°C.

[0048] In summary, the optimal reaction conditions screened out are: compound 1a and compound 2a are loaded into a high-temperature reaction tube, heated at 120°C for 2 hours without adding a catalyst and a solvent. After the reaction is completed, it is purified by 100-200 mesh silica gel column chromatography (the eluent used for column chromatography is dichloromethane and methanol in a volume ratio of 90:1 and 30:1), and then the solvent is dried by a rotary evaporator to obtain the product.

[0049] Example 1

[0050] The above optimal reaction conditions were used for substrate expansion to synthesize trifluoromethylquinazolinone derivatives as shown in the following table, a total of 38 compounds, see Table 2 for details.

[0051]

[0052] Table 2 Synthesis of 38 trifluoromethyl-containing quinazolinone derivatives

[0053]

[0054]

[0055] The spectral data of the 38 compounds synthesized in the above Table 2 are as follows.

[0056]

[0057] 3aa:White solid,mp:213.2-214.7℃. 1 H NMR (400MHz, CDCl3) δ10.13(s,1H),8.41(s,1H),8.23(d,J=7.9Hz,1H),7.71(m,2H),7.57(m,J=7.5,4.2H z,3H),7.45(t,J=7.5Hz,1H),7.32(m,J=12.4,5.4Hz,2H),4.03(d,J=15.3Hz,1H),3.58(d,J=15.3Hz,1H). 13 C NMR (101MHz, CDCl3) δ161.3,160.7,153.7,152.1,147.4,146.51,134.8,133.2,1 28.8,127.3,126.7,125.1,124.3,122.8,121.4,118.3,116.6,76.2,75.9,36.9. 19 F NMR(376MHz,CDCl3)δ-80.95.HRMS(APCI):m / z calcd for C 20 H 14 F3N2O4[M+H]+ 403.0906,found403.0923。

[0058]

[0059] 3ab:White solid,mp:257.2-259.8℃. 1 H NMR(400MHz,DMSO-d6)δ12.08(s,1H),8.43(s,1H),7.86(d,J=7.6Hz,1H),7.78(d,J=8.0Hz,1H),7.66(t,J=7.8Hz,1H),7.40(m,3H),7.20(d,J=8.1Hz,1H),4.34(d,J=15.7Hz,1H),3.37(s,1H),2.51(s,3H),2.20(s,4H). 13 C NMR(101MHz,DMSO-d6)δ162.2,159.0,153.8,151.3,146.8,143.2,132.9,129.4,128.4,126.9,125.6,125.2,124.0,123.0,119.2,116.1,75.4,75.2,74.9,74.6,36.4,20.8,12.6. 19 F NMR(376MHz,DMSO-d6)δ-78.52.HRMS(APCI):m / z calcd for C 22 H 18 F3N2O4[M+H] + 431.1219,found431.1190。

[0060]

[0061] 3ac:White solid,mp:219.6-221.0℃. 1 H NMR(400 MHz,CDCl3)δ10.35(s,1H),8.47(s,1H),8.10(d,J=7.8 Hz,1H),7.82(s,1H),7.57(m,3H),7.32(m,J=10.4,4.9 Hz,3H),4.16(d,J=15.4 Hz,1H),3.61(d,J=15.4 Hz,1H),2.50(s,3H). 13C NMR(101 MHz,CDCl3)δ161.9,160.3,153.8,151.3,146.4,145.9,135.5,134.6,133.1,128.7,126.8,125.0,124.5,122.4,121.2,118.4,116.6,76.1,75.8,36.4,17.7. 19 F NMR(376 MHz,CDCl3)δ-80.62.HRMS(APCI):m / z calcd forC 21 H 16 F3N2O4[M+H] + 417.1062,found 417.1083。

[0062]

[0063] 3ad:White solid,mp:207.8-209.9℃. 1 H NMR(400 MHz,DMSO-d6)δ12.13(s,1H),8.41(s,1H),7.84(m,2H),7.66(t,J=7.4 Hz,1H),7.46(d,J=8.3 Hz,3H),7.38(d,J=7.5Hz,1H),7.01(d,J=8.3 Hz,1H),4.21(d,J=15.4 Hz,1H),3.39(d,J=15.5 Hz,1H),2.36(s,3H). 13 C NMR(101 MHz,DMSO-d6)δ161.7,158.9,153.7,152.2,146.1,143.6,136.5,136.1,133.0,129.5,126.7,125.5,125.2,123.9,121.1,118.8,116.2,75.8,75.5,75.2,74.9,36.1,21.1. 19 F NMR(376 MHz,DMSO-d6)δ-78.12.HRMS(APCI):m / z calcd forC 21 H 16 F3N2O4[M+H] + 417.1062,found417.1029。

[0064]

[0065] 3ae:Yellow solid,mp:244.3-246.6℃.1 H NMR(400 MHz,DMSO-d6)δ12.73(s,1H),8.73(d,J=2.6 Hz,1H),8.40(m,3H),7.86(d,J=7.6 Hz,2H),7.67(d,J=7.4 Hz,2H),7.48(d,J=8.3Hz,1H),7.39(s,2H),7.25(d,J=9.0 Hz,2H),4.36(d,J=15.3 Hz,0H),3.45(s,0H). 13 C NMR(101 MHz,DMSO-d6)δ161.1,159.0,156.9,153.7,152.4,145.1,143.7,133.1,129.5,129.0,128.6,126.7,125.2,125.0,123.8,122.3,121.4,118.8,116.3,75.7,75.4,75.2,74.9,36.8. 19 F NMR(376MHz,DMSO-d6)δ-78.31.HRMS(APCI):m / z calcd forC 20 H 13 F3N3O6[M+H] + 448.0756,found448.0732。

[0066]

[0067] 3af:White solid,mp:210.4-212.7℃. 1 H NMR(400 MHz,DMSO-d6)δ12.57(s,1H),8.41(s,1H),8.24(s,1H),7.90(d,J=8.5 Hz,1H),7.83(d,J=7.8 Hz,1H),7.63(t,J=7.8Hz,1H),7.38(m,3H),7.25(d,J=8.5 Hz,1H),4.33(d,J=15.4 Hz,1H),3.43(d,J=15.4Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.1,159.0,155.7,153.7,150.7,143.6,133.0,130.9,129.5,128.4,126.9,126.7,125.5,125.1,123.6,122.8,121.5,118.8,116.2,75.7,75.5,75.2,74.9,36.6. 19F NMR(376MHz,DMSO-d6)δ-61.06,-78.31.HRMS(APCI):m / z calcdfor C 21 H 13 F6N2O4[M+H] + 471.0780,found 471.0797。

[0068]

[0069] 3ag:Yellow solid,mp:204.3-205.9℃. 1 H NMR(400 MHz,DMSO-d6)δ12.49(s,1H),8.31(s,1H),7.79(d,J=6.4 Hz,1H),7.59(d,J=7.2 Hz,1H),7.53(dt,J=8.3,2.9 Hz,2H),7.40(d,J=8.2 Hz,1H),7.33(d,J=7.6 Hz,1H),7.27(s,1H),4.31(d,J=15.4 Hz,1H),3.34(s,1H). 13 CNMR(101 MHz,DMSO-d6)δ160.4,159.2,158.1,158.1,158.0,158.0,155.6,155.4,153.9,152.9,143.0,135.0,134.9,132.7,129.3,126.7,125.5,125.0,123.9,123.8,123.7,119.0,116.1,110.4,110.1,110.1,109.9,106.9,106.9,106.7,106.7,75.7,75.4,75.1,74.8,36.3. 19 F NMR(376 MHz,DMSO-d6)δ-78.34,-110.70,-121.00.HRMS(APCI):m / z calcd for C 20 H 12 F5N2O4[M+H] + 439.0717,found 439.0701。

[0070]

[0071] 3ah:White solid,mp:199.2-200.2℃. 1H NMR(400 MHz,DMSO-d6)δ12.25(s,1H),8.40(s,1H),7.85(d,J=6.8 Hz,1H),7.65(d,J=7.3 Hz,1H),7.60(m,J=8.1,2.5 Hz,1H),7.47(d,J=8.3 Hz,1H),7.38(t,J=7.5 Hz,2H),7.14(m,J=10.9,8.2 Hz,1H),6.86(d,J=8.2 Hz,1H),4.24(d,J=15.4 Hz,1H),3.37(s,1H). 13 C NMR(101 MHz,DMSO-d6)δ162.2,159.6,159.0,154.1,153.7,150.4,143.5,135.5,133.0,129.5,126.7,125.2,123.9,122.9,118.8,116.2,113.3,113.1,110.9,75.7,75.4,75.1,74.8,36.1,19.0. 19 FNMR(376 MHz,DMSO-d6)δ-78.26,-111.33.HRMS(APCI):m / z calcd for C 20 H 13 F4N2O4[M+H] + 421.0811,found 421.0801。

[0072]

[0073] 3ai:White solid,mp:250.0-251.2℃. 1 H NMR(400 MHz,DMSO)δ12.66(s,1H),8.39(s,1H),7.93(d,J=2.4 Hz,1H),7.88(d,J=2.4 Hz,1H),7.84(d,J=7.7 Hz,1H),7.63(d,J=7.1 Hz,1H),7.43(d,J=8.3 Hz,1H),7.39-7.30(m,J=18.3,10.2 Hz,2H),4.43(d,J=15.6 Hz,1H),3.38(s,1H). 13C NMR(101 MHz,DMSO)δ160.5,159.2,154.3,154.0,144.1,143.2,134.3,132.7,131.8,130.6,129.3,126.8,125.6,125.0,124.4,123.9,119.4,116.0,75.6,75.3,75.0,74.8. 19 FNMR(376 MHz,DMSO)δ-78.52.HRMS(APCI):m / z calcd for C 20 H 12 Cl2F3N2O4[M+H] + 471.0126,found 471.0106。

[0074]

[0075] 3aj:White solid,mp:220.7-222.8℃. 1 H NMR(400 MHz,DMSO-d6)δ12.39(s,1H),8.40(s,1H),7.93(d,J=2.5 Hz,1H),7.82(m,J=7.8,1.4 Hz,1H),7.62(m,J=8.0,5.6Hz,2H),7.43(d,J=8.3 Hz,1H),7.33(d,J=7.4 Hz,1H),7.09(d,J=8.7 Hz,1H),4.37(s,1H),4.27(d,J=15.4 Hz,1H),3.45(s,1H). 13 C NMR(101 MHz,DMSO-d6)δ160.8,158.9,153.6,146.8,143.6,134.9,132.9,131.1,129.5,129.0,126.7,125.1,123.8,122.6,118.8,116.2,75.7,75.4,75.1,74.8,36.3,18.9. 19 F NMR(376 MHz,DMSO-d6)δ-78.25.HRMS(APCI):m / z calcd for C 20 H 13 ClF3N2O4[M+H] + 437.0516,found 437.0530。

[0076]

[0077] 3ak:White solid,mp:222.2-224.2℃. 1 H NMR(400 MHz,DMSO-d6)δ12.23(s,1H),8.39(s,1H),7.84(m,J=7.7,1.3 Hz,1H),7.65(t,J=7.1 Hz,1H),7.52(s,1H),7.46(d,J=8.3 Hz,1H),7.37(m,3H),6.97(d,J=8.1 Hz,1H),4.22(d,J=15.3 Hz,1H),3.36(s,1H). 13 C NMR(101 MHz,DMSO-d6)δ160.0,159.0,153.8,150.7,143.5,134.6,132.9,129.5,129.1,126.7,126.4,125.2,123.9,118.8,118.4,116.2,75.7,75.4,75.1,74.8,36.1. 19 FNMR(376 MHz,DMSO-d6)δ-78.24.HRMS(APCI):m / z calcd for C 20 H 13 ClF3N2O4[M+H] + 437.0516,found 437.0505。

[0078]

[0079] 3al:Yellow solid,mp:225.0-226.0℃. 1 H NMR(400 MHz,DMSO-d6)δ12.39(s,1H),8.40(s,1H),8.08(d,J=2.3 Hz,1H),7.82(d,J=7.7 Hz,1H),7.74(m,J=8.7,2.4 Hz,1H),7.63(m,J=11.4,4.2 Hz,1H),7.44(d,J=8.3 Hz,1H),7.35(m,J=8.9,5.3 Hz,2H),7.02(d,J=8.7 Hz,1H),4.26(d,J=15.4 Hz,1H),3.40(s,1H). 13C NMR(101 MHz,DMSO-d6)δ160.7,159.0,153.7,147.2,143.6,137.7,133.0,129.5,129.2,128.3,126.7,125.1,123.9,123.0,119.2,118.8,116.2,75.4,75.3,75.3,74.8,36.4. 19 F NMR(376 MHz,DMSO-d6)δ-78.25.HRMS(APCI):m / z calcd forC 20 H 13 BrF3N2O4[M+H] + 481.0011,found 481.0027。

[0080]

[0081] 3ba:Yellow solid,mp:205.1-206.4℃. 1 H NMR(400 MHz,DMSO-d6)δ12.21(s,1H),8.39(s,1H),8.12(d,J=2.4 Hz,1H),8.02(d,J=9.0 Hz,1H),7.78(d,J=2.4 Hz,1H),7.62(s,1H),7.40(m,3H),7.07(d,J=8.1 Hz,1H),4.23(d,J=15.6 Hz,1H),3.41(s,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.8,158.50,152.8,148.1,142.2,135.3,134.9,131.5,126.8,126.2,123.8,121.4,120.8,118.5,116.8,75.7,75.4,75.1,74.8,36.2. 19 F NMR(376MHz,DMSO-d6)δ-78.14.HRMS(APCI):m / z calcd for C 20 H 13 BrF3N2O4[M+H] + 481.0011,found480.9995。

[0082]

[0083] 3bc:White solid,mp:218.4-219.6℃. 1H NMR(400 MHz,DMSO-d6)δ12.19(s,1H),8.43(s,1H),8.17(d,J=2.3 Hz,1H),7.88(d,J=7.4 Hz,1H),7.81(m,J=8.8,2.4 Hz,1H),7.43(m,J=14.7,5.8 Hz,3H),7.28(t,J=7.6 Hz,1H),4.35(d,J=15.7 Hz,1H),3.38(s,1H),1.85(s,3H). 13 CNMR(101 MHz,DMSO-d6)δ162.1,158.5,152.8,151.5,147.0,142.0,135.2,134.8,131.4,127.0,126.8,126.2,123.9,121.3,121.0,118.5,116.8,75.56,75.3,75.0,74.7,55.4,36.4,16.9. 19 F NMR(376 MHz,DMSO-d6)δ-78.43.HRMS(APCI):m / z calcdfor C 21 H 15 BrF3N2O4[M+H] + 495.0167,found 495.0154。

[0084]

[0085] 3bd:White solid,mp:200.9-201.6℃. 1 H NMR(400 MHz,DMSO-d6)δ12.11(s,1H),8.39(s,1H),8.13(d,J=2.3 Hz,1H),7.79(m,2H),7.50(s,1H),7.44(t,J=6.5 Hz,2H),6.99(d,J=8.3Hz,1H),4.20(d,J=15.5 Hz,1H),3.38(d,J=15.7 Hz,1H),2.35(s,3H). 13 CNMR(101 MHz,DMSO-d6)δ161.7,158.5,152.7,152.0,146.1,142.3,136.5,136.1,135.3,131.5,129.5,126.7,125.5,123.8,121.1,120.7,118.5,116.7,75.7,75.4,75.1,74.8,36.1,21.1. 19F NMR(376 MHz,DMSO-d6)δ-78.07.HRMS(APCI):m / z calcd forC 21 H 15 BrF3N2O4[M+H] + 495.0167,found495.0143。

[0086]

[0087] 3bl:White solid,mp:187.2-189.4℃. 1 H NMR(400 MHz,DMSO-d6)δ12.41(s,1H),8.40(s,1H),8.13(m,J=16.5,2.2 Hz,2H),7.81(m,J=8.3,5.9,2.3 Hz,2H),7.44(t,J=9.6 Hz,2H),7.02(d,J=8.7 Hz,1H),4.26(d,J=15.6 Hz,1H),3.40(s,1H). 13 C NMR(101MHz,DMSO-d6)δ160.8,158.5,153.7,152.7,147.1,142.4,137.7,135.3,131.5,129.2,128.3,126.6,123.8(s,2H),123.0,120.7,119.1,118.5,116.8,75.7,75.4,75.1,74.8,56.5,36.4. 19 F NMR(376 MHz,DMSO-d6)δ-78.19.HRMS(APCI):m / z calcd forC 20 H 12 Br2F3N2O4[M+H] + 558.9116,found 558.9077。

[0088]

[0089] 3ca:Yellow solid,mp:222.4-224.9℃. 1H NMR(400 MHz,DMSO-d6)δ12.22(s,1H),8.41(s,1H),8.19(s,2H),8.04(d,J=6.9 Hz,1H),7.66(t,J=7.7 Hz,1H),7.58(s,1H),7.42(t,J=7.5Hz,1H),7.07(d,J=8.1 Hz,1H),4.21(d,J=15.6 Hz,1H),3.41(d,J=15.7Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.7,157.9,152.8,149.7,148.1,142.1,137.3,134.9,131.3,127.51,126.8,126.2,123.7,121.7,121.4,116.9,110.2,75.7,75.4,75.1,74.8,66.8,36.1. 19 F NMR(376MHz,DMSO-d6)δ-78.11(s,1H).HRMS(APCI):m / z calcd forC 20 H 12 Br2F3N2O4[M+H] + 558.9116,found 558.9084。

[0090]

[0091] 3cb:White solid,mp:221.4-222.8℃. 1 H NMR(400 MHz,DMSO-d6)δ12.09(s,1H),8.45(s,1H),8.20(d,J=9.4 Hz,2H),7.79(d,J=8.0 Hz,1H),7.49(s,1H),7.21(d,J=8.0Hz,1H),4.33(d,J=15.7 Hz,1H),3.39(s,1H),2.23(s,3H),1.81(s,3H). 13 C NMR(101 MHz,DMSO-d6)δ162.1,157.8,151.1,149.7,146.7,143.4,142.0,137.2,132.7,131.1,128.4,127.8,126.7,123.9,123.0,121.9,119.3,116.9,110.2,75.4,75.2,74.9,74.6,36.4,20.8,12.6. 19F NMR(376 MHz,DMSO-d6)δ-78.45.HRMS(APCI):m / z calcd forC 22 H 16 Br2F3N2O4[M+H] + 586.9429,found586.9394。

[0092]

[0093] 3cc:White solid,mp:161.9-163.9℃. 1 H NMR(400 MHz,DMSO-d6)δ12.18(s,1H),8.42(s,1H),8.20(m,J=6.6,2.2 Hz,2H),7.88(d,J=7.2 Hz,1H),7.48(d,J=6.6 Hz,2H),7.28(t,J=7.6Hz,1H),4.33(d,J=15.6 Hz,1H),3.36(d,J=15.8 Hz,1H),1.84(s,3H). 13 C NMR(101 MHz,DMSO-d6)δ162.1,157.8,151.4,149.8,146.9,141.9,137.2,135.1,134.7,131.1,127.8,126.7,126.3,123.8,121.9,121.4,116.9,110.2,75.5,75.3,75.0,74.7,55.4,36.3,16.8. 19 F NMR(376MHz,DMSO-d6)δ-78.39.HRMS(APCI):m / z calcd forC 21 H 14 Br2F3N2O4[M+H] + 572.9272,found 572.9242。

[0094]

[0095] 3cd:Yellow solid,mp:215.5-217.1℃. 1H NMR(400 MHz,DMSO-d6)δ12.12(s,1H),8.40(s,1H),8.18(s,2H),7.83(s,1H),7.59(s,1H),7.48(m,J=8.3,1.9 Hz,1H),6.99(d,J=8.3 Hz,1H),4.17(d,J=15.6 Hz,1H),3.40(d,J=15.7 Hz,1H),2.37(s,3H). 13 C NMR(101 MHz,DMSO-d6)δ161.7,157.8,151.9,149.7,146.0,142.1,137.3,136.6,136.2,131.3,127.5,126.7,125.52,123.7,121.7,121.2,116.9,110.2,75.7,75.4,75.1,74.8,66.8,36.0,21.12. 19 F NMR(376MHz,DMSO-d6)δ-78.04.HRMS(APCI):m / z calcd forC 21 H 14 Br2F3N2O4[M+H] + 572.9272,found 572.9244。

[0096]

[0097] 3ce:Yellow solid,mp:217.3-218.9℃. 1 H NMR(400 MHz,DMSO-d6)δ12.76(s,1H),8.74(d,J=2.6 Hz,1H),8.42(t,J=4.5 Hz,2H),8.19(s,2H),7.51(s,1H),7.26(d,J=9.0Hz,1H),4.33(d,J=15.6 Hz,1H),3.45(d,J=15.6 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.1,157.9,156.6,152.3,149.7,145.2,142.4,137.4,131.3,128.9,127.2,126.5,123.7,122.3,121.6,117.0(s,11H),110.3,75.3,75.0,74.7,36.6. 19F NMR(376 MHz,DMSO-d6)δ-78.24.HRMS(APCI):m / z calcd for C 20 H 11 Br2F3N3O6[M+H] + 603.8967,found603.8925。

[0098]

[0099] 3cg:White solid,mp:204.5-206.5℃. 1 H NMR(400 MHz,DMSO-d6)δ12.55(s,1H),8.34(s,1H),8.18(s,2H),7.62(m,2H),7.43(s,1H),4.33(d,J=15.5 Hz,1H),3.37(s,1H). 13 C NMR(101MHz,DMSO-d6)δ160.4,158.0,155.5,152.6,149.8,141.4,137.1,134.9,131.1,128.0,126.6,123.7,121.8,116.7,110.5,110.2,106.9,75.5,75.1,74.8,36.3. 19 FNMR(376 MHz,DMSO-d6)δ-78.23,-110.56,-121.79.HRMS(APCI):m / z calcd forC 20 H 10 Br2F5N2O4[M+H] + 594.8927,found594.8881。

[0100]

[0101] 3ci:White solid,mp:232.8-234.4℃. 1 H NMR(400 MHz,DMSO-d6)δ12.66(s,1H),8.36(s,1H),8.18(s,2H),7.94-7.92(m,J=6.4,2.4 Hz,2H),7.42(s,1H),4.39(d,J=15.5Hz,1H),3.37(s,1H). 13C NMR(101 MHz,DMSO-d6)δ160.5,158.0,154.0(s,4H),149.9,144.0,141.8,137.0,134.4,131.7,131.1,130.7,127.8,126.5,124.5,123.8,122.2,121.3,116.8,110.2,75.4,75.1,36.5. 19 F NMR(376 MHz,DMSO-d6)δ-78.35.HRMS(APCI):m / z calcd for C 20 H 10 Br2Cl2F3N2O4[M+H] + 626.8336,found 626.8307。

[0102]

[0103] 3cl:White solid,mp:107.3-108.6℃. 1 H NMR(400 MHz,DMSO-d6)δ12.43(s,1H),8.42(s,1H),8.18(m,J=7.4,2.2 Hz,2H),8.12(d,J=2.3 Hz,1H),7.81(m,J=8.7,2.3Hz,1H),7.51(s,1H),7.03(d,J=8.7 Hz,1H),4.24(d,J=15.7 Hz,1H),3.41(d,J=15.7Hz,1H). 13 C NMR(101MHz,DMSO-d6)δ160.7,157.8,153.5,149.7,147.7,147.1,144.7,142.4,141.1,139.1,137.5,136.2,135.1,134.1,133.0,132.2,131.3,130.4,129.4,128.3,128.1,75.0,74.7,36.23. 19 F NMR(376 MHz,DMSO-d6)δ-78.18.HRMS(APCI):m / zcalcd for C 20 H 11 Br3F3N2O4[M+H] + 636.8221,found 636.8177。

[0104]

[0105] 3da:Yellow solid,mp:212.5-214.0℃. 1 H NMR(400 MHz,DMSO-d6)δ11.79(s,1H),9.06(s,1H),8.57(d,J=7.4 Hz,1H),8.23(s,2H),8.18(m,J=11.1,4.3 Hz,1H),7.98(d,J=8.1 Hz,1H),7.91(t,J=7.6 Hz,1H),7.81(m,J=6.1,3.2 Hz,1H),7.74(m,J=7.0,3.7Hz,2H),4.75(d,J=15.9 Hz,1H),4.38(s,3H),4.13(d,J=15.9 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.8,158.7,153.1,148.1,146.6,143.9,143.0,134.8,129.6,126.8,126.1,125.3,125.1,123.9,121.4,121.0,120.5,119.4,115.0,75.7,75.4,75.1,74.8,36.1,19.0. 19 F NMR(376 MHz,DMSO-d6)δ-78.28(s,1H).HRMS(APCI):m / z calcd for C 21 H 16 F3N2O5[M+H] + 433.1011,found 433.1028。

[0106]

[0107] 3dc:White solid,mp:223.6-225.7℃. 1 H NMR(400 MHz,DMSO-d6)δ12.21(s,1H),8.42(s,1H),7.89(d,J=7.9 Hz,1H),7.46(d,J=7.2 Hz,1H),7.41(d,J=7.1 Hz,1H),7.31(m,4H),4.38(d,J=15.6 Hz,1H),3.93(s,3H),3.39(d,J=9.8 Hz,1H),1.87(s,3H). 13C NMR(101 MHz,DMSO-d6)δ162.1,158.7,151.7,146.9,146.6,143.5,143.1,134.9,126.9,126.2,125.8,125.1,123.9,123.7,121.3,120.4,119.7,115.0,75.6,75.3,75.0,74.7,36.4,16.9. 19 F NMR(376 MHz,DMSO-d6)δ-78.50.HRMS(APCI):m / z calcd forC 22 H 18 F3N2O5[M+H] + 447.1168,found447.1182。

[0108]

[0109] 3df:White solid,mp:204.2-206.3℃. 1 H NMR(400 MHz,DMSO-d6)δ12.59(s,1H),8.41(s,1H),8.29(s,1H),7.97(m,J=8.6,1.7 Hz,1H),7.35(m,J=16.7,12.3,3.6 Hz,6H),4.33(d,J=15.5 Hz,1H),3.94(s,3H),3.44(d,J=15.5 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.2,158.7,155.7,150.7,146.6,144.0,143.1,131.0,128.4,127.0,126.7,125.5,125.2,123.8,123.6,122.8,121.5,120.6,119.4,115.1,75.5,75.3,75.1,74.8,56.6,36.6. 19 F NMR(376 MHz,DMSO-d6)δ-60.99,-78.38.HRMS(APCI):m / z calcd forC 22 H 15 F6N2O5[M+H] + 501.0885,found501.0868。

[0110]

[0111] 3dg:White solid,mp:89.7-91.5℃. 1 H NMR(400 MHz,DMSO-d6)δ12.53(s,1H),8.33(s,1H),7.65-7.55(m,J=22.7,9.0 Hz,2H),7.33(dt,J=12.1,7.6 Hz,4H),4.34(d,J=15.5 Hz,1H),3.93(s,3H),3.36(d,J=15.7 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ160.5,159.2,154.3,154.0,144.1,143.2,134.3,132.7,131.8,130.6,129.3,126.8,125.6,125.0,124.4,123.8,119.4,116.0,75.6,75.3,75.0,74.8,66.8,36.4. 19 F NMR(376 MHz,DMSO-d6)δ-78.39,-110.70,-120.93.HRMS(APCI):m / z calcd for C 21 H 14 F5N2O5[M+H] + 469.0823,found 469.0790。

[0112]

[0113] 3dh:White solid,mp:193.2-195.7℃. 1 H NMR(400 MHz,DMSO-d6)δ12.24(s,1H),8.38(s,1H),7.59(m,1H),7.33(m,4H),7.13(t,J=9.5 Hz,1H),6.87(d,J=8.1 Hz,1H),4.23(d,J=15.5Hz,1H),3.92(s,3H),3.41(s,1H). 13 C NMR(101 MHz,DMSO-d6)δ162.16,159.6,159.2,158.7,154.2,150.3,146.6,143.8,143.0,135.5,126.7,125.2,123.9,122.9,120.6,119.4,115.1,113.3,113.1,110.9,36.1. 19F NMR(376 MHz,DMSO-d6)δ-78.33,-111.33.HRMS(APCI):m / z calcd forC 21 H 15 F4N2O5[M+H] + 451.0917,found 451.0899。

[0114]

[0115] 3di:White solid,mp:186.5-188.6℃. 1 H NMR(400 MHz,DMSO-d6)δ12.67(s,1H),8.36(s,1H),7.94-7.88(m,J=17.6,2.4 Hz,2H),7.39–7.36(m,J=7.2,1.9 Hz,1H),7.34–7.28(m,3H),4.43(d,J=15.7 Hz,1H),3.92(s,3H),3.37(d,J=15.7 Hz,1H). 13 C NMR(101MHz,DMSO-d6)δ160.5,159.0,154.3,146.6,144.0,143.4,134.3,131.8,130.6,126.7,125.7,125.0,124.4,123.8,120.4,119.9,114.8,75.6,75.3,75.0,74.7,56.6,36.4. 19 FNMR(376 MHz,DMSO-d6)δ-78.56.HRMS(APCI):m / z calcd for C 21 H 14 Cl2F3N2O5[M+H] + 501.0232,found 501.0211。

[0116]

[0117] 3dj:White solid,mp:148.3-150.3℃. 1H NMR(400 MHz,DMSO-d6)δ12.45(s,1H),8.43(s,1H),7.98(d,J=2.5 Hz,1H),7.68(m,J=8.7,2.5 Hz,1H),7.41(m,J=6.9,2.1Hz,2H),7.33(t,J=4.9 Hz,2H),7.16(d,J=8.7 Hz,1H),4.31(d,J=15.5 Hz,1H),3.95(s,3H),3.44(d,J=15.7 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ160.8,158.7,153.7,146.9,146.6,144.0,143.0,135.0,131.1,129.1,126.7,125.1,123.9,122.6,120.5,119.4,115.0,75.7,75.4,75.1,74.8,56.5,36.3. 19 FNMR(376 MHz,DMSO-d6)δ-78.34(s,1H).HRMS(APCI):m / z calcd for C 21 H 15 ClF3N2O5[M+H] + 467.0622,found 467.0598。

[0118]

[0119] 3dk:Yellow solid,232.7-234.9℃. 1 H NMR(400 MHz,DMSO-d6)δ12.24(s,1H),8.37(s,1H),7.53(t,J=8.0 Hz,1H),7.38(m,J=10.1,4.7 Hz,2H),7.32(m,J=13.1,6.5Hz,3H),6.99(d,J=8.1 Hz,1H),4.21(d,J=15.4 Hz,1H),3.92(s,3H),3.37(s,1H). 13 CNMR(101 MHz,DMSO-d6)δ159.9,158.7,153.9,150.7,146.6,143.8,143.1,134.7,132.8,129.2,126.7,126.4,125.2,123.9,120.6,119.4,118.4,115.1,75.6,75.4,75.1,74.8,56.6,36.0. 19F NMR(376 MHz,DMSO-d6)δ-78.32.HRMS(APCI):m / z calcd forC 21 H 15 ClF3N2O5[M+H] + 467.0622,found 467.0605。

[0120]

[0121] 3dl:White solid,mp:173.6-174.7℃. 1 H NMR(400 MHz,DMSO-d6)δ12.42(s,1H),8.40(s,1H),8.12(d,J=2.3 Hz,1H),7.80(m,J=8.7,2.4 Hz,1H),7.36(m,4H),7.06(d,J=8.7 Hz,1H),4.27(d,J=15.5 Hz,1H),3.94(s,3H),3.40(d,J=15.5 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ160.7,158.7,153.8,147.2,146.6,143.9,143.0,137.8,129.3,128.3,126.7,125.2,123.9,123.0,120.6,119.4,119.2,115.1,75.5,75.1,74.8,56.6,55.4,36.3. 19 F NMR(376 MHz,DMSO-d6)δ-78.33.HRMS(APCI):m / z calcd forC 21 H 15 BrF3N2O5[M+H] + 511.0166,found 511.0092。

[0122]

[0123] 3ea:Yellow solid,mp:170.7-171.5℃. 1H NMR(400 MHz,DMSO-d6)δ11.74(s,1H),9.01(s,1H),8.57(m,J=7.9,1.2 Hz,1H),8.18(d,J=8.7 Hz,3H),7.99(d,J=8.0 Hz,1H),7.91(t,J=7.1 Hz,1H),7.40(m,J=8.7,2.4 Hz,1H),7.32(d,J=2.4 Hz,1H),4.72(d,J=15.8 Hz,1H),4.36(s,3H),4.09(d,J=15.8 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ164.3,161.2,159.7,156.4,154.8,147.8,146.0,134.9,130.6,126.9,126.5,123.9,122.0,120.4,113.4,112.7,100.3,76.1,75.8,56.0,35.8. 19 F NMR(376 MHz,DMSO-d6)δ-80.16.HRMS(APCI):m / z calcd for C 21 H 16 F3N2O5[M+H] + 433.1011,found 433.1022。

[0124]

[0125] 3ec:White solid,mp:212.7-214.7℃. 1 H NMR(400 MHz,DMSO-d6)δ11.72(s,1H),9.03(s,1H),8.41(d,J=7.9 Hz,1H),8.22(d,J=8.7 Hz,1H),8.09(s,1H),8.02(d,J=7.2Hz,1H),7.79(d,J=7.5 Hz,1H),7.42(d,J=8.7 Hz,1H),7.34(s,1H),4.81(d,J=15.9Hz,1H),4.37(s,3H),4.08(s,1H),2.80(s,3H). 13C NMR(101 MHz,DMSO-d6)δ163.3,162.1,159.3,155.7,151.8,146.9,143.4,135.0,130.4,127.0,126.2,124.1,123.8,121.6,121.3,113.1,112.7,100.4,75.6,75.3,75.0,74.7,36.3,19.0,17.0. 19 F NMR(376 MHz,DMSO-d6)δ-78.64.HRMS(APCI):m / z calcdfor C 22 H 18 F3N2O5[M+H] + 447.1168,found447.1176。

[0126]

[0127] 3fe:Yellow solid,mp:184.7-185.6℃. 1 H NMR(400 MHz,DMSO-d6)δ12.74(s,1H),8.74(s,1H),8.41(m,J=7.7,3.8 Hz,2H),7.34(md,J=25.5,18.2,8.2 Hz,6H),4.37(d,J=15.4 Hz,1H),3.95(s,4H),3.45(d,J=15.4 Hz,1H). 13 C NMR(101 MHz,DMSO-d6)δ161.1,158.7,156.9,152.4,146.6,145.1,144.0,143.1,129.0,128.7,126.7,125.1,123.8,122.3,121.4,120.6,119.4,115.1,75.7,75.4,75.1,74.8,56.6,36.8. 19 F NMR(376 MHz,DMSO-d6)δ-78.39.HRMS(APCI):m / z calcd for C 21 H 15 F3N3O7[M+H] + 478.0862,found478.0785。

[0128]

[0129] 3gh:White solid,mp:210.2-210.9℃. 1H NMR(400 MHz,DMSO-d6)δ12.19(s,1H),8.32(s,1H),7.60(m,3H),7.47(m,2H),7.36(d,J=8.4 Hz,2H),7.14(d,J=2.6 Hz,2H),6.88(d,J=8.2Hz,1H),4.24(d,J=15.4 Hz,1H),3.37(s,2H),2.36(s,4H). 13 C NMR(101MHz,DMSO-d6)δ162.2,159.5,159.1,154.1,151.9,150.4,143.4,135.5,134.4,133.8,129.1,128.4,126.7,125.1,123.9,122.9,119.0,118.6,117.3,115.9,115.2,113.8,75.1,36.1,20.7. 19 F NMR(376 MHz,DMSO-d6)δ-78.30,-111.35.HRMS(APCI):m / z calcd forC 21 H 15 F4N2O4[M+H] + 435.0968,found 435.0947。

[0130]

[0131] 3gj:White solid,mp:217.9-219.5℃. 1 H NMR(400 MHz,DMSO-d6)δ12.38(s,1H),8.32(s,1H),7.95(d,J=2.4 Hz,1H),7.65(m,J=8.7,2.5 Hz,1H),7.60(s,1H),7.45(d,J=8.5 Hz,1H),7.33(d,J=8.4 Hz,2H),7.09(d,J=8.7 Hz,1H),4.26(d,J=15.5 Hz,1H),3.37(d,J=15.7 Hz,2H),2.34(s,4H). 13 C NMR(101 MHz,DMSO-d6)δ160.8,159.1,153.6,151.9,146.9,143.5,135.0,134.4,133.8,131.1,129.3,126.7,125.1,123.9,122.6,118.6,116.0,75.7,75.4,75.1,74.8,36.3,20.7.19 F NMR(376 MHz,DMSO-d6)δ-78.29.HRMS(APCI):m / z calcd forC 21 H 15 ClF3N2O4[M+H] + 451.0672, found 451.0649.

[0132] Antibacterial experiment:

[0133] According to the agricultural industry standard of the People's Republic of China (NY / T1156.2-2006), the mycelium growth rate method was used to determine the bactericidal or antibacterial activity of the above-synthesized compounds. The specific process is as follows:

[0134] The codes and names of the pathogenic bacteria strains tested are: A: Fusarium graminearum (F.graminearum, from wheat, gibberellosis), B: Fusarium moniliforme (F.moniliforme wilt), C: Fusarium oxysporum (F.oxysporum, black rot), D: Nicotianae, E: Rhizoctonia solani (R.solani); the strains are from Henan Agricultural University, and the main purpose is to test and verify the bactericidal or antibacterial activity of the compounds of the present application, and the strains used in the experiment themselves are not special.

[0135] Before the experiment, the obtained pathogenic bacteria strains are activated and cultured (the activation culture can be carried out by conventional techniques in the art, which is not the innovation of the present application and will not be described in detail), which can be referred to as follows:

[0136] 1) Prepare PDA medium suitable for the growth of the strain;

[0137] 2) Restoring the strain from a refrigerated state to room temperature;

[0138] 3) For the original strain, select the colonies that thrive in the culture medium (the part at the edge of the bacterial cake), select some of the colonies and cut the bacterial cake along the edge of the colony with a 6.5 mm diameter puncher under sterile conditions, inoculate the bacterial cake on the PDA culture medium with an inoculator, with the mycelium side facing up, cover the dish, and place the culture dish in a constant temperature incubator at 25°C for culture. Repeat this step 2-3 times to obtain a culture medium for well-growing colonies. When the diameter of the control colony expands to more than 6 cm, take it out and refrigerate it for activity experiments.

[0139] The preparation process of PDA medium is as follows:

[0140] Weigh 200g of potatoes, cut into small pieces, add 1000mL of distilled water, and steam for 30 minutes after boiling; weigh 20g of glucose and 18g of agar; filter the steamed potatoes with degreased gauze, add nearly 1000mL of water, add glucose to dissolve, pour into a pot, boil, add agar, heat and stir until uniform; pour into a beaker, add water to 1000mL, stir well, and dispense into 30mL conical flasks and double seal.

[0141] Sterilization, transplanting and processing:

[0142] Wrap the inoculation loop and inoculation needle with newspapers, and place the prepared PDA medium in a sterilization box, and heat it to 120 degrees for 30 minutes to sterilize it; weigh an appropriate amount of compound into a conical flask, add 0.66mL of DMSO to dissolve it, place it in a sterile operation box for ultraviolet sterilization, and inoculate it for use;

[0143] The temperature of the sterilization box dropped to about 50°C for subsequent treatment: add 2.65mL of Tween and 250ml of distilled water to a 250mL conical flask, mix well, and prepare Tween water for use. Mix the PDA culture medium, 2.65mL of Tween water, and the DMSO solution containing the compound and divide them into culture dishes in triplicate. After the culture medium solidifies, transplant the pathogens. After the transplanting is completed, seal it with a sealing film and place it in an incubator at 25°C for cultivation. The growth of the pathogen is determined to be completed when the bacterial cake of the blank control group grows to 80% of the culture dish. Measure the data and calculate the inhibition rate.

[0144] The calculation formula of the inhibition rate is: inhibition rate I = (D0-Dt) / D0*100%;

[0145] Among them, D0 is the average diameter of mycelium in the control disk, and Dt is the average diameter of mycelium in the sample disk. The antibacterial effects of different compounds on five pathogens are compared in the table below.

[0146] Table 3 Antibacterial effect of each compound (concentration: 500 mg / L)

[0147]

[0148]

[0149] Using triadimefon at a concentration of 10 mg / L as a positive control, it can be seen from the results in Table 3 that most of the trifluoromethyl quinazolinone derivatives of the present invention have a certain degree of fungicidal activity. Overall, this type of compound has the best antibacterial effect on Rhizoctonia solani.

[0150] In summary, the trifluoromethyl-containing quinazolinone derivatives of the present invention can be used to prepare antibacterial or antibacterial drugs.

Claims

1. A trifluoromethyl-containing quinazolinone derivative, characterized in that: Its structural formula is as follows: Among them, the substituent R 1 , R 2 The composition is shown in the following table, wherein the trifluoromethyl-containing quinazolinone derivative is at least one of the 17 compounds in the table; 。 2. The method for preparing the trifluoromethyl quinazolinone derivatives according to claim 1, characterized in that: The trifluoroacetyl coumarin compound 1 and the quinazolinone compound 2 are placed in a reaction tube and reacted at 110-130° C. for 1-3 hours. After the reaction is completed, the residue is purified by silica gel column chromatography to obtain the target product derivative 3; The reaction synthesis route is as follows: 。 3. The method for preparing a trifluoromethyl quinazolinone derivative according to claim 2, characterized in that: The molar ratio of the trifluoroacetylcoumarin compound 1 to the quinazolinone compound 2 is 1:1-2.

4. The method for preparing a trifluoromethyl quinazolinone derivative according to claim 2, characterized in that: The reaction was carried out at 120°C for 2 hours.

5. The method for preparing a trifluoromethyl quinazolinone derivative according to claim 2, characterized in that: The residue was purified by 100-200 mesh silica gel column chromatography.

6. The method for preparing a trifluoromethyl quinazolinone derivative according to claim 5, characterized in that: The eluents used for silica gel column chromatography were dichloromethane and methanol in a volume ratio of 90:1 and 30:

1.

7. Use of the trifluoromethyl-containing quinazolinone derivatives according to claim 1 in the preparation of antibacterial or antibacterial drugs, characterized in that: The fungus is at least one of Fusarium graminearum, Fusarium moniliforme, Fusarium oxysporum, Phytophthora nicotianae and Rhizoctonia solani.

Citation Information

Patent Citations

  • Trifluoromethyl coumarin-containing tertiary alcohol derivative as well as preparation method and application thereof

    CN114989145A